PrimeMSK

N/A

Report date: 2022/12/25 13:45:31

Base Information

Drug NamePrimeMSK
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesDiabetes ComplicationsSkin Diseases +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThomas Advanced Medical LLC
China Registration ClassN/A

Develop Information

Active CompaniesThomas Advanced Medical LLC
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesDiabetes ComplicationsSkin Diseases +[8] 
Inactive IndicationsCardiovascular DiseasesNervous System DiseasesMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A